Each hour of TV watching increases risk of diabetes by 3.4 percent
the ONA take:
According to a study published in the journal Diabetologia, researchers from the University of Pittsburgh in Pittsburgh, Pennsylvania, have found that each hour spent watching television daily increases the risk of developing diabetes by 3.4%.For the study, researchers analyzed data from participants in the Diabetes Prevention Program (DPP), which included 3,234 overweight adults.
Results showed that those who made lifestyle changes had a reduction in self-reported TV watching time and the largest reduction in time spent watching TV and sitting at work.
The researchers also found that the risk of diabetes increased about 3.4% for each hour spent watching TV each day. The findings suggest that future lifestyle interventions should emphasize less sitting.
Each hour spent watching television daily increases the risk of developing diabetes by 3.4%.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|